Evans John M.'s Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Jul 29, 2022
- Accession no.
- 0000899243-22-027077
- Filed
- Jul 29, 2022
- Trade date
- Jul 28, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 9 non-derivative transactions. Open-market sales total $3.29M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Evans John M.CIK 0001786304 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2022 | Common Stock | SSaleDisposed | −10,181 | $64.87F2 | −$660,441.47 | 1,108,339 | Direct | |
| Jul 28, 2022 | Common Stock | SSaleDisposed | −15,236 | $65.82F3 | −$1,002,833.52 | 1,093,103 | Direct | |
| Jul 28, 2022 | Common Stock | SSaleDisposed | −1,562 | $66.74F4 | −$104,247.88 | 1,091,541 | Direct | |
| Jul 28, 2022 | Common Stock | SSaleDisposed | −2,848 | $67.80F5 | −$193,094.4 | 1,088,693 | Direct | |
| Jul 28, 2022 | Common Stock | SSaleDisposed | −173 | $68.49 | −$11,848.77 | 1,088,520 | Direct | |
| Jul 28, 2022 | Common Stock | SSaleDisposed | −6,953 | $64.88F6 | −$451,110.64 | 136,047 | Indirect | |
| Jul 28, 2022 | Common Stock | SSaleDisposed | −10,599 | $65.92F7 | −$698,686.08 | 125,448 | Indirect | |
| Jul 28, 2022 | Common Stock | SSaleDisposed | −201 | $66.61F8 | −$13,388.61 | 125,247 | Indirect | |
| Jul 28, 2022 | Common Stock | SSaleDisposed | −2,247 | $67.82F9 | −$152,391.54 | 123,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.43 to $65.42, inclusive.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.43 to $66.34, inclusive.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.44 to $67.37, inclusive.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.45 to $67.87, inclusive.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.43 to $65.38, inclusive.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.46 to $66.45, inclusive.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.50 to $66.61, inclusive.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.72 to $68.49, inclusive.
Referenced by the price of 1 transaction in Table I.